Marc Robillard

Co-Founder & Chief Scientific Officer Tagworks Pharmaceuticals

Wednesday 10th March 2027

Translating Early Clinical & Preclinical Data Into a Protein Design Framework for Safer, Non-Internalizing ADC Targets